The drug is marketed as a treatment for Alzheimer’s disease, but it’s also a way to help people who are addicted to drugs or alcohol.
It has been approved in the US and the European Union for treating alcoholics and other drug abusers.
Advertisement The company behind it, Lazada Health Products, says its drug can be used to treat chronic pain and other conditions including anxiety, depression and anxiety disorders.
“We believe that by combining these therapeutic components, our products are the only option available today to effectively address chronic pain, anxiety, and other chronic conditions,” the company said in a statement.
“As a result, Lazadaxedil is a top priority for us at Lazada.”
The drug was approved in 2016 in the UK and New Zealand.
In Australia, it’s available under the trade name Lazadylix and is sold as a capsule.
The company says its products are a form of pain relief and can help people stop smoking.
“Our product has been specifically designed to provide relief for chronic pain as well as anxiety,” Lazada said.
“The drug is safe and well tolerated and can be prescribed as a medication in the setting of a chronic pain condition, or to help manage symptoms such as depression and/or anxiety.”
The drug has been available for a decade and is available in Australia and New York.
But there are some concerns about the safety of the drug and the price it costs.
A recent review by the Australian Medical Association said it was “not clear” whether the drug was effective in treating pain.
“It is not clear whether the use of this drug is consistent with the standard of care for the use and misuse of pain medications, including benzodiazepines,” the review said.
It also found there were concerns about its long-term safety.
According to the AMA, a large proportion of the pain medication used in Australia is being prescribed to people who have chronic conditions such as diabetes, cancer and arthritis.
Australian Health Minister Peter Dutton has defended the approval of the new drug, saying it was important to keep Australians safe.
He said there were also other drug options for the same conditions.
‘I think people will be happy to hear’Mr Dutton said the drugs had been approved “to treat chronic conditions”.
“I think that people will probably be very happy to have a choice of the drugs, and I think we have made a very good choice for Australia,” he said.
”We have made sure that people can have choices.
“Topics:health,diseases-and-disorders,health,health-policy,drugs-and_pharmaceuticals,united-states,australia,canberra-2600,new-zealand,uk,nz,aruba,aotearoa-2650,south-africa,aesthetics-and/or-attachments,healthcare-facilities,aecdote-health-research,medicines-and%28prescribing,health_administration,aesthetic,laboratory-drugs,research,aussies-new-shores,latin-america More stories from New South Wales